S
DNMR

SignatureFD’s Danimer Scientific, Inc. DNMR Stock Holding History

SignatureFD’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,318
Closed -$23.9K – 3442
2024
Q3 		$23.9K Hold
1,318
– – ﹤0.01% 1952
2024
Q2 		$31.8K Hold
1,318
– – ﹤0.01% 1741
2024
Q1 		$57.5K Hold
1,318
– – ﹤0.01% 1473
2023
Q4 		$53.8K Hold
1,318
– – ﹤0.01% 1421
2023
Q3 		$109K Hold
1,318
– – ﹤0.01% 1000
2023
Q2 		$125K Hold
1,318
– – ﹤0.01% 950
2023
Q1 		$182K Hold
1,318
– – 0.01% 756
2022
Q4 		$94.3K Buy
1,318
+25
+2% +$2.37K ﹤0.01% 1038
2022
Q3 		$153K Buy
1,293
+30
+2% +$5.34K 0.01% 770
2022
Q2 		$230K Hold
1,263
– – 0.01% 647
2022
Q1 		$296K Hold
1,263
– – 0.01% 586
2021
Q4 		$431K Buy
1,263
+61
+5% +$33.6K 0.01% 447
2021
Q3 		$786K Hold
1,202
– – 0.03% 244
2021
Q2 		$1.2M Buy
+1,202
New +$1.2M 0.05% 152

Other funds holding DNMR

DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
SAM
Synergy Asset Management Vancouver, Washington $1.06B AUM 36.26% 1-Year Est. Return

SignatureFD's DNMR Position: Q4 2024 in Review

SignatureFD sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 1,318 shares — an estimated $23.9K sold.

SignatureFD first reported a position in DNMR in Q2 2021 and held it in 14 quarters. The position peaked at $1.2M in Q2 2021. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.

  • SignatureFD reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
  • SignatureFD sold 1,318 Danimer Scientific, Inc. shares in Q4 2024, an estimated $23.9K.
  • SignatureFD first reported a position in Danimer Scientific, Inc. in Q2 2021 and held it in 14 quarters.
  • SignatureFD's Danimer Scientific, Inc. position peaked at $1.2M in Q2 2021.
  • 3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.

Based on SignatureFD's 13F filing for Q4 2024, filed 10 Feb 2025.